tiprankstipranks
Trending News
More News >
Healthcare Services (HCSG)
NASDAQ:HCSG
Advertisement

Healthcare Services (HCSG) AI Stock Analysis

Compare
201 Followers

Top Page

HCSG

Healthcare Services

(NASDAQ:HCSG)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 4o)
Rating:72Outperform
Price Target:
$20.50
▲(8.98% Upside)
The overall stock score for HCSG is driven by strong financial performance and positive technical indicators. The earnings call provided a positive outlook, although valuation concerns due to a high P/E ratio and lack of dividend yield slightly dampen the score. The company's robust cash flow and low debt levels are significant strengths, positioning it well for future growth.
Positive Factors
Revenue Growth
The consistent revenue growth of 8.5% YoY indicates strong market demand and effective client retention strategies, supporting long-term business expansion.
Cash Flow and Balance Sheet
Robust cash flow and a strong balance sheet provide financial stability and flexibility, enabling strategic investments and resilience against economic fluctuations.
Client Retention
High client retention and new client acquisitions enhance revenue stability and growth potential, reinforcing the company's competitive position in the healthcare services market.
Negative Factors
Profitability Margins
Declining gross profit margins suggest challenges in cost management, potentially impacting long-term profitability if not addressed effectively.
SG&A Expenses
Rising SG&A expenses could pressure operating margins, necessitating improved cost control measures to maintain financial health and competitiveness.
Genesis Healthcare Bankruptcy
The bankruptcy of a major client like Genesis Healthcare poses a risk to revenue stability, requiring strategic adjustments to mitigate potential financial impacts.

Healthcare Services (HCSG) vs. SPDR S&P 500 ETF (SPY)

Healthcare Services Business Overview & Revenue Model

Company DescriptionHealthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary. The Housekeeping segment engages in the cleaning, disinfecting, and sanitizing of resident rooms and common areas of the client's facility, as well as laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at a client's facility. The Dietary segment provides food purchasing, meal preparation, and professional dietitian services, which include the development of menus that meet the dietary needs of residents. This segment also offers on-site management and clinical consulting services to facilities. As of December 31, 2021, the company provided its services to approximately 3,000 facilities. Healthcare Services Group, Inc. was incorporated in 1976 and is based in Bensalem, Pennsylvania.
How the Company Makes MoneyHCSG generates revenue primarily through service contracts with healthcare facilities, which include long-term care facilities, hospitals, and rehabilitation centers. The company charges clients based on a fee-for-service model, where revenue is derived from contracted service agreements that outline specific service expectations and pricing. Key revenue streams include daily service fees for housekeeping and dietary services, as well as additional charges for specialized services or equipment. HCSG also benefits from long-term contracts, which provide stable and predictable income. Significant partnerships with healthcare organizations and an emphasis on compliance with health and safety regulations further enhance HCSG's market position and contribute to its earnings.

Healthcare Services Earnings Call Summary

Earnings Call Date:Oct 22, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 18, 2026
Earnings Call Sentiment Positive
The earnings call reflects a strong performance in revenue growth, cash flow, and client retention, with a solid outlook on labor market conditions and a proactive share buyback strategy. However, there are ongoing challenges with Genesis Healthcare's bankruptcy and higher SG&A expenses.
Q3-2025 Updates
Positive Updates
Strong Revenue Growth
Revenue was reported at $464.3 million, marking an 8.5% increase over the prior year.
Positive Cash Flow and Balance Sheet
Cash flow from operations was reported at $71.3 million, with a strong balance sheet showing cash and marketable securities of $207.5 million.
New Client Wins and High Retention
New client wins and high retention rates drove top-line growth, contributing to the highest revenue growth since Q1 of 2018.
Labor Market Stability
Labor market conditions were favorable with sufficient applications to fill job openings, supporting growth prospects.
Share Buyback Program
Repurchased $27.3 million of common stock in the third quarter, totaling $42 million year-to-date.
Negative Updates
Genesis Healthcare Bankruptcy
Ongoing bankruptcy proceedings at Genesis Healthcare, though services continue without disruption.
Higher SG&A Expenses
SG&A was reported at $50.5 million, with a $3.7 million increase in deferred compensation and $2.1 million of professional fees related to the ERC.
Company Guidance
During the Healthcare Services Group's (HCSG) third quarter 2025 earnings call, CEO Ted Wahl highlighted a robust performance with a revenue increase of 8.5% year-over-year, reaching $464.3 million. Segment revenues were reported at $211.8 million for Environmental Services and $252.5 million for Dietary Services. The company managed its cost of services at 79.2%, with a notable benefit from the Employee Retention Credit (ERC) of $34.2 million. SG&A expenses were $50.5 million, with a longer-term target to manage these costs into the 8.5% to 9.5% range. Segment margins were 10.7% for Environmental Services and 5.1% for Dietary Services. Net income stood at $43 million, translating to a diluted earnings per share of $0.59, including a $0.36 per share benefit from the ERC. Cash flow from operations was $71.3 million, adjusted to $87.1 million after accounting for payroll accrual decreases. The company ended the quarter with $207.5 million in cash and marketable securities, while also repurchasing $27.3 million of its stock during the quarter. Looking ahead, HCSG anticipates Q4 revenue between $460 million and $470 million and remains focused on driving growth, managing costs, and optimizing cash flow.

Healthcare Services Financial Statement Overview

Summary
Healthcare Services demonstrates solid financial health with strong cash flow and a robust balance sheet. Revenue growth is moderate, and profitability margins are under pressure, suggesting a need for improved cost management. The low debt levels provide financial flexibility, positioning the company well for future growth opportunities.
Income Statement
65
Positive
The company shows moderate revenue growth with a TTM growth rate of 2.04%. Gross profit margin has slightly decreased from 13.29% in 2024 to 12.49% in TTM, indicating some pressure on cost management. Net profit margin remains stable around 2.2%, but is relatively low for the industry. EBIT and EBITDA margins have slightly declined, suggesting potential challenges in operational efficiency.
Balance Sheet
75
Positive
The balance sheet is strong with a low debt-to-equity ratio of 0.01 in TTM, indicating low leverage and financial stability. Return on equity is reasonable at 7.59%, though it has slightly decreased from previous years. The equity ratio remains healthy, reflecting a solid capital structure.
Cash Flow
70
Positive
Cash flow performance has improved significantly with a TTM free cash flow growth rate of 73.78%. The operating cash flow to net income ratio is 0.49, indicating decent cash generation relative to net income. Free cash flow to net income ratio is high at 0.94, reflecting strong cash conversion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.81B1.72B1.67B1.69B1.64B1.76B
Gross Profit225.94M228.09M214.75M193.84M230.57M267.99M
EBITDA72.20M73.96M75.21M62.94M77.88M144.83M
Net Income39.73M39.47M38.39M34.24M48.54M98.68M
Balance Sheet
Total Assets804.30M802.77M790.65M718.33M777.53M785.03M
Cash, Cash Equivalents and Short-Term Investments177.46M107.31M147.46M121.48M185.19M264.34M
Total Debt6.22M16.45M36.23M33.10M17.80M16.66M
Total Liabilities201.86M302.85M334.04M292.16M324.85M304.57M
Stockholders Equity602.44M499.93M456.62M426.17M452.68M480.46M
Cash Flow
Free Cash Flow157.92M24.47M38.09M-13.38M31.42M212.87M
Operating Cash Flow163.78M30.80M43.50M-8.17M37.11M217.21M
Investing Cash Flow2.23M6.05M-3.29M2.58M-22.99M-36.84M
Financing Cash Flow-69.74M-31.05M-12.15M-38.93M-82.65M-68.37M

Healthcare Services Technical Analysis

Technical Analysis Sentiment
Positive
Last Price18.81
Price Trends
50DMA
16.33
Positive
100DMA
15.28
Positive
200DMA
13.53
Positive
Market Momentum
MACD
0.78
Negative
RSI
68.35
Neutral
STOCH
74.31
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCSG, the sentiment is Positive. The current price of 18.81 is above the 20-day moving average (MA) of 16.94, above the 50-day MA of 16.33, and above the 200-day MA of 13.53, indicating a bullish trend. The MACD of 0.78 indicates Negative momentum. The RSI at 68.35 is Neutral, neither overbought nor oversold. The STOCH value of 74.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HCSG.

Healthcare Services Risk Analysis

Healthcare Services disclosed 23 risk factors in its most recent earnings report. Healthcare Services reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Healthcare Services Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$1.87B18.1910.65%2.07%25.19%13.44%
$1.56B13.8914.27%-3.08%
$1.33B34.818.07%6.26%-19.33%
$872.34M32.2811.44%30.58%24.86%
$2.06B131.1211.53%
$790.63M-40.13%-14.33%-398.68%
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HCSG
Healthcare Services
18.81
7.84
71.47%
AMN
AMN Healthcare Services
20.63
-17.31
-45.62%
MD
Pediatrix Medical Group
17.87
5.55
45.05%
NHC
National Healthcare
120.85
7.49
6.61%
PNTG
Pennant Group
25.03
-6.94
-21.71%
AVAH
Aveanna Healthcare Holdings
9.86
5.21
112.04%

Healthcare Services Corporate Events

Healthcare Services Group Reports Strong Q3 Earnings
Oct 24, 2025

Healthcare Services Group’s recent earnings call painted a picture of robust financial health, marked by impressive revenue growth, strong cash flow, and high client retention rates. The sentiment was generally positive, with optimism about labor market conditions and a strategic share buyback program. However, challenges remain, particularly concerning Genesis Healthcare’s bankruptcy and increased SG&A expenses.

Healthcare Services Group Surpasses Q3 Expectations
Oct 23, 2025

Healthcare Services Group, Inc. is a prominent provider of housekeeping, laundry, dining, and nutritional services within the healthcare industry, known for its nearly five decades of experience in enhancing operational, regulatory, and financial outcomes for its clients.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 26, 2025